Card image cap

Amy Klobuchar's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Democratic/Farmer/Labor for U.S. Senate (MN) - Sr

Page 1 of 4

Date Title
10/14/2022 Letter to Hon. Alejandro Mayorkas, Secretary of Homeland Security, Hon. Louis DeJoy, Postmaster General, and Hon. Antony J. Blinken, Secretary of State - Klobuchar, Portman Push for Full Implementation of Legislation to Tackle Illegal Opioids Entering the U.S.
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/01/2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
12/10/2021 Letter to Hon. Antony J. Blinken, Secretary of State, Hon. Louis DeJoy, Postmaster General, and Hon. Alejandro Mayorkas, Secretary of Homeland Security - Klobuchar, Portman Press Biden Administration to Take Action to Prevent Illegal Opioids from Entering the U.S.
02/18/2021 Letter to Joe Biden, President of the United States - Baldwin, Shaheen Lead Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/18/2021 Letter to Joe Biden, President of the United States - Luján Joins Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/04/2021 Letter to Dr. Nora D. Volkow, Director of The National Institute on Drug Abuse - Brown, Capito Lead Letter Supporting Enhanced Research and Development of Methamphetamine Treatment Options
11/10/2020 Letter to the Hon. William Barr, Attorney General for the Dept. of Justice - Durbin, Senators Call On DOJ To Stop Plans To Make Purdue Pharma A Public Benefit Corporation
09/15/2020 Letter to Mr. Stephen J. Ubl, President and CEO of PhRMA - Senators Demand Big Pharma Allow Low-income Patients to Access Lifesaving, Discounted 340B Drugs and Care
05/22/2020 Letter to Scott Gast, Deputy Counsel to the President - Menendez, Warren, Colleagues Request Newly Appointed "Therapeutics Czar" to Divest from Financial Interest, Resign to Boards of any Pharmaceutical, Medical and Biotech Companies
05/19/2020 Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader - U.S. Senators Jeanne Shaheen and Tammy Baldwin Lead Colleagues in Calling for Increased Funding to Treat and Prevent Substance Use Disorders in Coronavirus Relief Package
04/16/2020 Letter to the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader, the Hon. Richard Shelby, Chairman of the Senate Appropriations Committee, and the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee - Senators Shaheen & Hassan Call for Increased Investments to Address Mental Health Needs, Including Substance Use Disorder, Resulting from COVID-19 Pandemic
12/17/2019 Letter to the Board of Directors at Perdue Pharma Inc. - Senators Call on Perdue Pharma to Cancel $1.3 Million Bonus for CEO
10/29/2019 Letter to the Hon. Alex Azar II, Secretary of the U.S. Department of Health and Human Services - Amid Delay, Senator Kaine Urges Trump Administration to Prioritize Children's Health and Keep Promise to Ban Flavored E-Cigarettes
07/11/2019 Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Durbin, Lee, Senators Press HHS About Public Health Impact Of "Fentanyl-Related" Scheduling
06/18/2019 Letter to the Hon. William Barr, Attorney General of the United States, and the Hon. Kevin McAleenan, Acting Secretary of Homeland Security - Senators Call on DOJ and DHS to Stop Implementation of Guidance Denying Citizenship Over Cannabis-related Activities
07/06/2018 Letter to the Centers for Disease Control and Prevention - Senators Call on CDC to better Support Forensic Medicine as Overdose Deaths Continue to Rise
04/18/2018 Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Stabenow, Peters Call on Administration to Take Immediate Action to Reduce Price of Naloxone, a Life-Saving Opioid Overdose Reversal Drug
03/08/2018 Letter to the Hon Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon Roy Blunt, Chairman of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee, and the Hon Patty Murray, Ranking Member of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee - Senator Cantwell, Colleagues Call for Increased Investment in Student Health, Safety
03/05/2018 Letter to the Hon. Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon. Roy Blunt, Chairman of the Subcommittee on Labor, Health and Human Services, and Education, and the Hon. Patty Murray, Ranking Member of the Subcommittee on Labor, Health and Human Services, and Education - Advocate for Resources to Combat Opioid Crisis in Foster Care System
02/22/2018 Letter to Mr. Sundar Pichai, CEO, Google, Mr. Satya Nadella, CEO, Microsoft, Mr. Ben Silbermann, CEO and Co-Founder, Pinterest, and Ms. Mayer, CEO of Yahoo - Clamp Down on Illegal Online Drug Sales and Advertising
11/08/2017 Letter to Jeff Sessions, Attorney General - Provide Guidance on Boosting Support for Forensic Labs In Efforts to Combat Opioid Epidemic
11/07/2017 Letter to Mr. Brenton L. Saunders, CEO, Allergan plc - Monopoly Keeps Price of Drug High, Limits Competition
11/03/2017 Letter to the Hon. Donald J. Trump, President - Support Funding to Stem Opioid Epidemic
10/25/2017 Letter to President Donald J. Trump - Allow Government to Negotiate Lower Prices for Naloxone

Page 1 of 4
arrow_upward